SCHEMBL13507978

SCHEMBL13507978

Cn1c2cc(-c3cc4ccccc4cc3-c3ccccc3)ccc2c2c3ccccc3c3c4ccc(-c5cc6ccccc6cc5-c5ccccc5)cc4n(C)c3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.44
▸ MAOB P27338 2/20 0.44
▸ PTGS2 P35354 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ RET P07949 2/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ ACACA Q13085 1/20 0.37
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TERT O14746 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ TLR7 Q9NYK1 1/20 0.36
▸ BRD9 Q9H8M2 1/20 0.36
▸ BRD7 Q9NPI1 1/20 0.36
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507036 0.87 PTGS2 (0.42) LIMK1MAOBPTGS2HSD17B10RET
SCHEMBL13507749 0.87 CYP11B1 (0.42) LIMK1MAOBHSD17B10RETRXRA
SCHEMBL13507633 0.86 MAOB (0.50) LIMK1MAOBHSD17B10KMT2ARXRA
SCHEMBL13507867 0.85 MAOB (0.57) LIMK1MAOBHSD17B10RXRARXRB
SCHEMBL13507467 0.84 KDM4E (0.40) LIMK1MAOBHSD17B10KDM4EMAPT
SCHEMBL13507908 0.84 LIMK1 (0.41) LIMK1MAOBHSD17B10RETKMT2A
SCHEMBL13507734 0.84 LIMK1 (0.44) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL13508170 0.83 CA12 (0.43) LIMK1MAOBRETRXRARXRB
SCHEMBL13507850 0.82 LIMK1 (0.46) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL13507906 0.82 LIMK1 (0.41) LIMK1MAOBHSD17B10KMT2ARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 LIMK1 222/4885MAOB 446/4885PTGS2 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback